Connection
Kimberly Jordan to Antigens, CD19
This is a "connection" page, showing publications Kimberly Jordan has written about Antigens, CD19.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.350 |
|
|
|
-
Bair SM, Pinto N, Roth A, Verneris M, Haverkos B, Nicklawsky A, Ohm A, Jordan K, Murphy LA, Marians R, Mallo R, Orentas R, Adams C, Kamdar M, Fry T. Feasibility and Safety of a Novel CD19-Directed CAR T-Cell Therapy in Patients with R/R B-Cell Non-Hodgkin Lymphoma. Transplant Cell Ther. 2026 Oct; 32(10):1268.e1-1268.e12.
Score: 0.220
-
Zhang W, Jordan KR, Schulte B, Purev E. Characterization of clinical grade CD19 chimeric antigen receptor T cells produced using automated CliniMACS Prodigy system. Drug Des Devel Ther. 2018; 12:3343-3356.
Score: 0.130